Medullary thyroid cancer: An experience from a tertiary care hospital of a developing country
Background: Medullary thyroid carcinoma (MTC) is a rare type of thyroid cancer that occasionally occurs as part of MEN2A. The universal treatment of MTC is total thyroidectomy with central lymph node dissection. For disease progression, carcinoembryonic antigen (CEA) and calcitonin (CTN) need to be...
Main Authors: | Sajjad A Khan, Abdul Aziz, Umer A Esbhani, Muhammad Q Masood |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2022;volume=26;issue=1;spage=68;epage=72;aulast=Khan |
Similar Items
-
MEDULLARY THYROID CANCER, AN EXPERIENCE FROM A TERTIARY CARE HOSPITAL OF A DEVELOPING COUNTRY
by: Sajjad Ali Khan, et al.
Published: (2021-11-01) -
PD-L1 Expression in Medullary Thyroid Carcinoma and Its Association with Clinicopathological Findings
by: Yasemin KEMAL, et al.
Published: (2022-05-01) -
Clinicopathological Profile of Medullary Thyroid Carcinoma—Could We Predict Aggressive Behavior?
by: Simona Eliza Giusca, et al.
Published: (2023-01-01) -
Targeted Therapy for Medullary Thyroid Cancer: A Review
by: S. R. Priya, et al.
Published: (2017-10-01) -
Comparison Between Clinicopathological Characteristics, BRAF V600E and TERT Promoter Mutation of Familial Non-Medullary Thyroid Carcinomas, and Sporadic Case
by: Tian Yang, et al.
Published: (2021-12-01)